{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:14Z","timestamp":1786979774997,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T00:00:00Z","timestamp":1486771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003331","name":"Provincial Health Services Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-137103"],"award-info":[{"award-number":["MOP-137103"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00213-017-4551-7","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T01:48:37Z","timestamp":1486777717000},"page":"1535-1547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence"],"prefix":"10.1007","volume":"234","author":[{"given":"Peter D","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M","family":"Gicas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor S","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara N","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Boyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric M","family":"Procyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen E","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Panenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Vila-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"William MacEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,11]]},"reference":[{"key":"4551_CR1","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.4088\/JCP.13078tx2c","volume":"75","author":"A Abi-Dargham","year":"2014","unstructured":"Abi-Dargham A (2014) Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry 75:e31","journal-title":"J Clin Psychiatry"},{"key":"4551_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2008-2231-21-30","volume":"21","author":"Z Alam Mehrjerdi","year":"2013","unstructured":"Alam Mehrjerdi Z, Barr AM, Noroozi A (2013) Methamphetamine-associated psychosis: a new health challenge in Iran. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 21:30","journal-title":"Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences"},{"key":"4551_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-3956(74)90064-8","volume":"11","author":"B Angrist","year":"1974","unstructured":"Angrist B, Sathananthan G, Wilk S, Gershon S (1974) Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 11:13\u201323","journal-title":"J Psychiatr Res"},{"key":"4551_CR4","unstructured":"APA (2000) Diagnostic and statistical manual of mental disorders (4th ed., Text Revision), Washington, DC"},{"key":"4551_CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2005.03.012","volume":"29","author":"AM Barr","year":"2005","unstructured":"Barr AM, Markou A (2005) Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev 29:675\u2013706","journal-title":"Neurosci Biobehav Rev"},{"key":"4551_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-6147(02)02086-2","volume":"23","author":"AM Barr","year":"2002","unstructured":"Barr AM, Markou A, Phillips AG (2002) A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 23:475\u2013482","journal-title":"Trends Pharmacol Sci"},{"key":"4551_CR7","first-page":"301","volume":"31","author":"AM Barr","year":"2006","unstructured":"Barr AM, Panenka WJ, Macewan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T (2006) The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 31:301\u2013313","journal-title":"J Psychiatry Neurosci"},{"key":"4551_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-9964(98)00023-1","volume":"31","author":"MR Basso","year":"1998","unstructured":"Basso MR, Nasrallah HA, Olson SC, Bornstein RA (1998) Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophr Res 31:99\u2013111","journal-title":"Schizophr Res"},{"key":"4551_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10550490490512834","volume":"13","author":"SL Batki","year":"2004","unstructured":"Batki SL, Harris DS (2004) Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am J Addict 13:461\u2013470","journal-title":"Am J Addict"},{"key":"4551_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","volume":"50","author":"A Bechara","year":"1994","unstructured":"Bechara A, Damasio AR, Damasio H, Anderson SW (1994) Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50:7\u201315","journal-title":"Cognition"},{"key":"4551_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JCP.0000000000000314","volume":"35","author":"AK Bershad","year":"2015","unstructured":"Bershad AK, Kirkpatrick MG, Seiden JA, de Wit H (2015) Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol 35:308\u2013312","journal-title":"J Clin Psychopharmacol"},{"key":"4551_CR12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ajad.12160","volume":"24","author":"CA Bousman","year":"2015","unstructured":"Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I (2015) Typologies of positive psychotic symptoms in methamphetamine dependence. Am J Addict 24:94\u201397","journal-title":"Am J Addict"},{"key":"4551_CR13","unstructured":"Brady KT, Lydiard RB, Malcolm R, Ballenger JC (1991) Cocaine-induced psychosis. J Clin Psychiatry 52:509\u2013512"},{"key":"4551_CR14","unstructured":"Brandt J, Benedict RH (2001) Hopkins verbal learning test\u2014revised: professional manual. Psychological Assessment Resources"},{"key":"4551_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198916010-00001","volume":"16","author":"U Busto","year":"1989","unstructured":"Busto U, Bendayan R, Sellers EM (1989) Clinical pharmacokinetics of non-opiate abused drugs. Clin Pharmacokinet 16:1\u201326","journal-title":"Clin Pharmacokinet"},{"key":"4551_CR16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-8993(94)90523-1","volume":"668","author":"DM Camp","year":"1994","unstructured":"Camp DM, Browman KE, Robinson TE (1994) The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res 668:180\u2013193","journal-title":"Brain Res"},{"key":"4551_CR17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57:1117\u20131127","journal-title":"Biol Psychiatry"},{"key":"4551_CR18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12889-015-2627-z","volume":"16","author":"T Cheng","year":"2016","unstructured":"Cheng T, Johnston C, Kerr T, Nguyen P, Wood E, DeBeck K (2016) Substance use patterns and unprotected sex among street-involved youth in a Canadian setting: a prospective cohort study. BMC Public Health 16:4","journal-title":"BMC Public Health"},{"key":"4551_CR19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/10826080902869620","volume":"45","author":"WS Cheng","year":"2010","unstructured":"Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL (2010) Binge use and sex and drug use behaviors among HIV(\u2212), heterosexual methamphetamine users in San Diego. Subst Use Misuse 45:116\u2013133","journal-title":"Subst Use Misuse"},{"key":"4551_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(02)00302-X","volume":"61","author":"R Emsley","year":"2003","unstructured":"Emsley R, Rabinowitz J, Torreman M (2003) The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res 61:47\u201357","journal-title":"Schizophr Res"},{"key":"4551_CR21","volume-title":"Best estimate clinical evaluation and diagnosis form (BECED)","author":"J Endicott","year":"1988","unstructured":"Endicott J (1988) Best estimate clinical evaluation and diagnosis form (BECED). Department of Research Assessment and Training, New York State Psychiatric Institute, New York"},{"key":"4551_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.181.5.393","volume":"181","author":"M Farrell","year":"2002","unstructured":"Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, Taylor C (2002) Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 181:393\u2013398","journal-title":"Br J Psychiatry"},{"key":"4551_CR23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681\u2013698","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4551_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrn3901","volume":"16","author":"A Fornito","year":"2015","unstructured":"Fornito A, Zalesky A, Breakspear M (2015) The connectomics of brain disorders. Nat Rev Neurosci 16:159\u2013172","journal-title":"Nat Rev Neurosci"},{"key":"4551_CR25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuroimage.2008.07.020","volume":"43","author":"JS Fowler","year":"2008","unstructured":"Fowler JS, Volkow ND, Logan J, Alexoff D, Telang F, Wang GJ, Wong C, Ma Y, Kriplani A, Pradhan K, Schlyer D, Jayne M, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog K (2008) Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. NeuroImage 43:756\u2013763","journal-title":"NeuroImage"},{"key":"4551_CR26","unstructured":"Fray PJ, Robbins TW, Sahakian BJ (1996) Neuorpsychiatyric applications of CANTAB. International Journal of Geriatric Psychiatry"},{"key":"4551_CR27","doi-asserted-by":"crossref","unstructured":"Gicas KM, Giesbrecht CJ, Panenka WJ, Lang DJ, Smith GN, Vila-Rodriguez F, Leonova O, Jones AA, Barr AM, Procyshyn RM, Buchanan T, MacEwan GW, Su W, Vertinsky AT, Rauscher A, Honer WG, Thornton AE (2016) Structural brain markers are differentially associated with neurocognitive profiles in socially marginalized people with multimorbid illness. Neuropsychology","DOI":"10.1037\/neu0000304"},{"key":"4551_CR28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/13803395.2014.963519","volume":"36","author":"KM Gicas","year":"2014","unstructured":"Gicas KM, Vila-Rodriguez F, Paquet K, Barr AM, Procyshyn RM, Lang DJ, Smith GN, Baitz HA, Giesbrecht CJ, Montaner JS, Krajden M, Krausz M, MacEwan GW, Panenka WJ, Honer WG, Thornton AE (2014) Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness. J Clin Exp Neuropsychol 36:1009\u20131022","journal-title":"J Clin Exp Neuropsychol"},{"key":"4551_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1360-0443.1995.tb02199.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607\u2013614","journal-title":"Addiction"},{"key":"4551_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","volume":"7","author":"KM Grant","year":"2012","unstructured":"Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J NeuroImmune Pharmacol 7:113\u2013139","journal-title":"J NeuroImmune Pharmacol"},{"key":"4551_CR31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10550490050172209","volume":"9","author":"D Harris","year":"2000","unstructured":"Harris D, Batki SL (2000) Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 9:28\u201337","journal-title":"Am J Addict"},{"key":"4551_CR32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.irn.2015.02.004","volume":"120","author":"J Harro","year":"2015","unstructured":"Harro J (2015) Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol 120:179\u2013204","journal-title":"Int Rev Neurobiol"},{"key":"4551_CR33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-4159.2009.06357.x","volume":"111","author":"L Hondebrink","year":"2009","unstructured":"Hondebrink L, Meulenbelt J, Timmerman JG, van den Berg M, Westerink RH (2009) Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure. J Neurochem 111:624\u2013633","journal-title":"J Neurochem"},{"key":"4551_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2006.08.031","volume":"549","author":"J Izawa","year":"2006","unstructured":"Izawa J, Yamanashi K, Asakura T, Misu Y, Goshima Y (2006) Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. Eur J Pharmacol 549:84\u201390","journal-title":"Eur J Pharmacol"},{"key":"4551_CR35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNN.0b013e31816bdf90","volume":"21","author":"E Jacobs","year":"2008","unstructured":"Jacobs E, Fujii D, Schiffman J, Bello I (2008) An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia. Cogn Behav Neurol 21:98\u2013103","journal-title":"Cogn Behav Neurol"},{"key":"4551_CR36","doi-asserted-by":"crossref","first-page":"e008876","DOI":"10.1136\/bmjopen-2015-008876","volume":"5","author":"AA Jones","year":"2015","unstructured":"Jones AA, Vila-Rodriguez F, Leonova O, Langheimer V, Lang DJ, Barr AM, Procyshyn RM, Smith GN, Schultz K, Buchanan T, Krausz M, Montaner JS, MacEwan GW, Rauscher A, Panenka WJ, Thornton AE, Honer WG (2015) Mortality from treatable illnesses in marginally housed adults: a prospective cohort study. BMJ Open 5:e008876","journal-title":"BMJ Open"},{"key":"4551_CR37","doi-asserted-by":"crossref","first-page":"e79754","DOI":"10.1371\/journal.pone.0079754","volume":"8","author":"AA Jones","year":"2013","unstructured":"Jones AA, Vila-Rodriguez F, Panenka WJ, Leonova O, Strehlau V, Lang DJ, Thornton AE, Wong H, Barr AM, Procyshyn RM, Smith GN, Buchanan T, Krajden M, Krausz M, Montaner JS, Macewan GW, Nutt DJ, Honer WG (2013) Personalized risk assessment of drug-related harm is associated with health outcomes. PLoS One 8:e79754","journal-title":"PLoS One"},{"key":"4551_CR38","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"KM Kahlig","year":"2005","unstructured":"Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102:3495\u20133500","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4551_CR39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/00952990.2012.704461","volume":"38","author":"RK Kalapatapu","year":"2012","unstructured":"Kalapatapu RK, Bedi G, Haney M, Evans SM, Rubin E, Foltin RW (2012) The subjective effects of cocaine: relationship to years of cocaine use and current age. Am J Drug Alcohol Abuse 38:530\u2013534","journal-title":"Am J Drug Alcohol Abuse"},{"key":"4551_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugalcdep.2009.10.006","volume":"107","author":"R Kalayasiri","year":"2010","unstructured":"Kalayasiri R, Gelernter J, Farrer L, Weiss R, Brady K, Gueorguieva R, Kranzler HR, Malison RT (2010) Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug Alcohol Depend 107:196\u2013201","journal-title":"Drug Alcohol Depend"},{"key":"4551_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2005.12.002","volume":"84","author":"R Kalayasiri","year":"2006","unstructured":"Kalayasiri R, Kranzler HR, Weiss R, Brady K, Gueorguieva R, Panhuysen C, Yang BZ, Farrer L, Gelernter J, Malison RT (2006a) Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend 84:77\u201384","journal-title":"Drug Alcohol Depend"},{"key":"4551_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pbb.2006.02.005","volume":"83","author":"R Kalayasiri","year":"2006","unstructured":"Kalayasiri R, Sughondhabirom A, Gueorguieva R, Coric V, Lynch WJ, Morgan PT, Cubells JF, Malison RT (2006b) Self-reported paranoia during laboratory \u201cbinge\u201d cocaine self-administration in humans. Pharmacol Biochem Behav 83:249\u2013256","journal-title":"Pharmacol Biochem Behav"},{"key":"4551_CR43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"4551_CR44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","volume":"23","author":"SR Kay","year":"1988","unstructured":"Kay SR, Opler LA, Lindenmayer JP (1988) Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99\u2013110","journal-title":"Psychiatry Res"},{"key":"4551_CR45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drugalcdep.2011.03.030","volume":"118","author":"SJ Kuramoto","year":"2011","unstructured":"Kuramoto SJ, Bohnert AS, Latkin CA (2011) Understanding subtypes of inner-city drug users with a latent class approach. Drug Alcohol Depend 118:237\u2013243","journal-title":"Drug Alcohol Depend"},{"key":"4551_CR46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/NMD.0000000000000059","volume":"201","author":"T Lecomte","year":"2013","unstructured":"Lecomte T, Mueser KT, MacEwan W, Thornton AE, Buchanan T, Bouchard V, Goldner E, Brink J, Lang D, Kang S, Barr AM, Honer WG (2013) Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J Nerv Ment Dis 201:1085\u20131089","journal-title":"J Nerv Ment Dis"},{"key":"4551_CR47","doi-asserted-by":"crossref","unstructured":"Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proceedings of the Association of American Physicians 111: 99\u2013108","DOI":"10.1046\/j.1525-1381.1999.09218.x"},{"key":"4551_CR48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0010-440X(86)90003-9","volume":"27","author":"JP Lindenmayer","year":"1986","unstructured":"Lindenmayer JP, Kay SR, Friedman C (1986) Negative and positive schizophrenic syndromes after the acute phase: a prospective follow-up. Compr Psychiatry 27:276\u2013286","journal-title":"Compr Psychiatry"},{"key":"4551_CR49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0091-3057(96)00449-2","volume":"57","author":"RH Mach","year":"1997","unstructured":"Mach RH, Nader MA, Ehrenkaufer RL, Line SW, Smith CR, Gage HD, Morton TE (1997) Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol Biochem Behav 57:477\u2013486","journal-title":"Pharmacol Biochem Behav"},{"key":"4551_CR50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.genm.2010.09.003","volume":"7","author":"JJ Mahoney 3rd","year":"2010","unstructured":"Mahoney JJ 3rd, Hawkins RY, De La Garza R 2nd, Kalechstein AD, Newton TF (2010) Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gender medicine 7:414\u2013421","journal-title":"Gender medicine"},{"key":"4551_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10550490701861201","volume":"17","author":"JJ Mahoney 3rd","year":"2008","unstructured":"Mahoney JJ 3rd, Kalechstein AD, De La Garza R 2nd, Newton TF (2008) Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. Am J Addict 17:83\u201398","journal-title":"Am J Addict"},{"key":"4551_CR52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1360-0443.2002.00143.x","volume":"97","author":"T Matsumoto","year":"2002","unstructured":"Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, Okudaira K, Iseki E, Sakai T, Kosaka K (2002) Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 97:809\u2013817","journal-title":"Addiction"},{"key":"4551_CR53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40\u201366","journal-title":"Med Care"},{"key":"4551_CR54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","volume":"70","author":"R McKetin","year":"2013","unstructured":"McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL (2013) Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA psychiatry 70:319\u2013324","journal-title":"JAMA psychiatry"},{"key":"4551_CR55","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","volume":"101","author":"R McKetin","year":"2006","unstructured":"McKetin R, McLaren J, Lubman DI, Hides L (2006) The prevalence of psychotic symptoms among methamphetamine users. Addiction 101:1473\u20131478","journal-title":"Addiction"},{"key":"4551_CR56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psychres.2012.09.023","volume":"206","author":"S Medhus","year":"2013","unstructured":"Medhus S, Mordal J, Holm B, Morland J, Bramness JG (2013) A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Res 206:17\u201321","journal-title":"Psychiatry Res"},{"issue":"7","key":"4551_CR57","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.addbeh.2005.08.003","volume":"31","author":"M Mooney","year":"2006","unstructured":"Mooney M, Sofuoglu M, Dudish-Poulsen S, Hatsukami DK (2006) Preliminary observations of paranoia in a human laboratory study of cocaine. Addict Behav 31(7):1245\u20131251","journal-title":"Addict Behav"},{"key":"4551_CR58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/jnp.12.1.4","volume":"12","author":"DS O'Leary","year":"2000","unstructured":"O'Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC (2000) Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J Neuropsychiatry Clin Neurosci 12:4\u201315","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4551_CR59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","volume":"129","author":"WJ Panenka","year":"2013","unstructured":"Panenka WJ, Procyshyn RM, Lecomte T, MacEwan GW, Flynn SW, Honer WG, Barr AM (2013) Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 129:167\u2013179","journal-title":"Drug Alcohol Depend"},{"key":"4551_CR60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","volume":"53","author":"V Peralta","year":"1994","unstructured":"Peralta V, Cuesta MJ (1994) Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res 53:31\u201340","journal-title":"Psychiatry Res"},{"key":"4551_CR61","unstructured":"Satel SL, Edell WS (1991) Cocaine-induced paranoia and psychosis proneness. Am J Psychiatr 148(12):1708\u20131711"},{"key":"4551_CR62","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00702-005-0383-4","volume":"113","author":"K Schwartz","year":"2006","unstructured":"Schwartz K, Weizman A, Rehavi M (2006) The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles. J Neural Transm 113:1347\u20131352","journal-title":"J Neural Transm"},{"key":"4551_CR63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(97)00067-3","volume":"88","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997a) Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav Brain Res 88:251\u2013260","journal-title":"Behav Brain Res"},{"key":"4551_CR64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(24)36838-7","volume":"282","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997b) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther 282:561\u2013573","journal-title":"J Pharmacol Exp Ther"},{"key":"4551_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v21n01_06","volume":"21","author":"SL Simon","year":"2002","unstructured":"Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W (2002) Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61\u201374","journal-title":"J Addict Dis"},{"key":"4551_CR66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","volume":"50","author":"MJ Smith","year":"2009","unstructured":"Smith MJ, Thirthalli J, Abdallah AB, Murray RM, Cottler LB (2009) Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry 50:245\u2013250","journal-title":"Compr Psychiatry"},{"issue":"2","key":"4551_CR67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4603(86)90040-7","volume":"11","author":"MB Sobell","year":"1986","unstructured":"Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E (1986) The reliability of a timeline method for assessing normal drinker college students\u2019 recent drinking history: utility for alcohol research. Addict Behav 11(2):149\u2013161","journal-title":"Addict Behav"},{"key":"4551_CR68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13104-015-1501-5","volume":"8","author":"VM Tang","year":"2015","unstructured":"Tang VM, Lang DJ, Giesbrecht CJ, Panenka WJ, Willi T, Procyshyn RM, Vila-Rodriguez F, Jenkins W, Lecomte T, Boyda HN, Aleksic A, MacEwan GW, Honer WG, Barr AM (2015) White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection. BMC Res Notes 8:515","journal-title":"BMC Res Notes"},{"key":"4551_CR69","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1017\/S0033291715000574","volume":"45","author":"A Trotta","year":"2015","unstructured":"Trotta A, Murray RM, Fisher HL (2015) The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. Psychol Med 45:2481\u20132498","journal-title":"Psychol Med"},{"key":"4551_CR70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jcop.20418","volume":"39","author":"J Tsai","year":"2011","unstructured":"Tsai J, Stroup TS, Rosenheck RA (2011) Housing arrangements among a national sample of adults with chronic schizophrenia living in the United States: a descriptive study. J Community Psychol 39:76\u201388","journal-title":"J Community Psychol"},{"key":"4551_CR71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","volume":"16","author":"OM Vallersnes","year":"2016","unstructured":"Vallersnes OM, Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Dargan PI (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:293","journal-title":"BMC Psychiatry"},{"key":"4551_CR72","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/13803390802484797","volume":"31","author":"EA Plas van der","year":"2009","unstructured":"van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706\u2013719","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2\u20133","key":"4551_CR73","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.psychres.2012.07.043","volume":"200","author":"E Vergara-Moragues","year":"2012","unstructured":"Vergara-Moragues E, Gonz\u00e1lez-Saiz F, Lozano OM, Espinosa PB, Calder\u00f3n FF, Bilbao-Acebos I, Garc\u00eda MP, Garc\u00eda AV (2012) Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders. Psychiatry Res 200(2\u20133):734\u2013741","journal-title":"Psychiatry Res"},{"key":"4551_CR74","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1176\/appi.ajp.2013.12111439","volume":"170","author":"F Vila-Rodriguez","year":"2013","unstructured":"Vila-Rodriguez F, Panenka WJ, Lang DJ, Thornton AE, Vertinsky T, Wong H, Barr AM, Procyshyn RM, Sidhu JJ, Smith GN, Buchanan T, Krajden M, Krausz M, Montaner JS, Macewan GW, Honer WG (2013) The hotel study: multimorbidity in a community sample living in marginal housing. Am J Psychiatry 170:1413\u20131422","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"4551_CR75","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.psychres.2012.04.008","volume":"200","author":"F Vorspan","year":"2012","unstructured":"Vorspan F, Brousse G, Bloch V, Bellais L, Romo L, Guillem E, Coeuru P, L\u00e9pine J-P (2012) Cocaine-induced psychotic symptoms in French cocaine addicts. Psychiatry Res 200(2\u20133):1074\u20131076","journal-title":"Psychiatry Res"},{"key":"4551_CR76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00104-7","volume":"68","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, Ortengren A, de Wit H (2002) The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend 68:23\u201333","journal-title":"Drug Alcohol Depend"},{"key":"4551_CR77","first-page":"39","volume-title":"Predictors of one-year cognitive decline in a marginally housed, multimorbid sample Department of Psychology","author":"K Waclawik","year":"2016","unstructured":"Waclawik K (2016) Predictors of one-year cognitive decline in a marginally housed, multimorbid sample Department of Psychology. Simon Fraser University, Burnaby, p 39"},{"key":"4551_CR78","unstructured":"Wechsler D (2001) Wechsler Test of Adult Reading (WTAR). The Psychological Corporation"},{"key":"4551_CR79","doi-asserted-by":"crossref","unstructured":"Willi TS, Barr AM, Gicas K, Lang DJ, Vila-Rodriguez F, Su W, Thornton AE, Leonova O, Giesbrecht CJ, Procyshyn RM, Rauscher A, MacEwan WG, Honer WG, Panenka WJ (2016a) Characterization of white matter integrity deficits in cocaine-dependent individuals with substance-induced psychosis compared with non-psychotic cocaine users. Addiction biology","DOI":"10.1111\/adb.12363"},{"key":"4551_CR80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.psychres.2016.04.059","volume":"240","author":"TS Willi","year":"2016","unstructured":"Willi TS, Honer WG, Thornton AE, Gicas K, Procyshyn RM, Vila-Rodriguez F, Panenka WJ, Aleksic A, Leonova O, Jones AA, MacEwan GW, Barr AM (2016b) Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence. Psychiatry Res 240:336\u2013342","journal-title":"Psychiatry Res"},{"key":"4551_CR81","doi-asserted-by":"crossref","unstructured":"Willi TS, Lang DJ, Honer WG, Smith GN, Thornton AE, Panenka WJ, Procyshyn RM, Vila-Rodriguez F, Su W, Vertinsky AT, Leonova O, Rauscher A, MacEwan GW, Barr AM (2016c) Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users. Schizophr Res","DOI":"10.1016\/j.schres.2016.08.001"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4551-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:04:27Z","timestamp":1749960267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,11]]},"references-count":81,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["4551"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4551-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,11]]}}}